Related Experiment Video
Updated: Jun 1, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
Current approaches in CRISPR-Cas systems for hereditary diseases
Swati Singh1, Divakar Raj1, Ashish Mathur1
1School of Health Sciences & Technology, UPES, Dehradun, Uttarakhand, India.
CRISPR-Cas gene editing offers a revolutionary approach to treating inherited disorders by precisely correcting disease-causing mutations. This technology holds promise for a wide range of genetic conditions, ushering in a new era of precision medicine.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- CRISPR-Cas technologies have transformed genetic engineering.
- Significant potential exists for treating inherited disorders through precise DNA editing.
Purpose of the Study:
- To discuss the CRISPR-Cas9 mechanism and its significance in treating hereditary disorders.
- To explore the potential of CRISPR-based therapies for various genetic diseases.
Main Methods:
- Utilizing specific guide RNAs to target and edit disease-causing mutations.
- Research and optimization of CRISPR-Cas9, CRISPR-Cas12, and CRISPR-Cas13 systems.
- Development of base editing technology for simultaneous or precise nucleotide correction.
Main Results:
- CRISPR-Cas enables precise correction of mutations in single-gene and complex polygenic diseases.
- CRISPR-based therapies are predicted to treat cancer predisposition, neurological, and cardiovascular conditions.
- Combined approaches like gene therapy with stem cells enhance CRISPR efficacy and reduce side effects.
Conclusions:
- CRISPR-Cas technology is paving the way for efficient and curative therapies for genetic diseases.
- The advancement of multiplex editing and base editing tools will further enhance therapeutic capabilities.
- CRISPR-based treatments personalized to individual genetic profiles promise a new era of precision medicine.
More Related Videos
08:20A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
CRISPR
Homologous Recombination
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
What is Genetic Engineering?
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...